KDR and prostate neoplasm: The VEGFR-1 is present in vascular-endothelial cells and prostatic tumor cells, in addition to hematopoietic cells and monocytes; however, some of the VEGF biological effects on endothelial cells are also given through VEGFR-2, expressed by both prostate tumor cells and stroma [46, 47].